We are live on ! Find out more
RVMD icon

Revolution Medicines
RVMD

77 hedge funds and large institutions have $1.49B invested in Revolution Medicines in 2020 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 24 increasing their positions, 16 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 16

45% more capital invested

Capital invested by funds: $1.03B → $1.49B (+$460M)

24% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 17

17% more funds holding in top 10

Funds holding in top 10: 6 → 7 (+1)

5% more funds holding

Funds holding: 73 → 77 (+4)

2.46% less ownership

Funds ownership: 82.5% → 80.05% (-2.5%)

Holders
77
Holders Change
+4
Holders Change %
+5.48%
% of All Funds
1.58%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.14%
New
21
Increased
24
Reduced
16
Closed
17
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$39M
2
BlackRock
BlackRock
New York
+$9.68M
3
JP Morgan Chase
JP Morgan Chase
New York
+$8.18M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$7.2M
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$4.22M

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$18.9M
2
RG
Redmile Group
California
-$6.65M
3
O
OrbiMed
New York
-$6.57M
4
ACA
Avoro Capital Advisors
New York
-$4.59M
5
Jennison Associates
Jennison Associates
New York
-$4.39M
Name Holding Trade Value Shares
Change 		Change in
Stake
T. Rowe Price Associates
26
T. Rowe Price Associates
Maryland
$4.21M +$1.19M +37,939 +40%
N
27
Nuveen
North Carolina
$4.07M +$1.52M +48,352 +60%
Goldman Sachs
28
Goldman Sachs
New York
$4.07M +$1.99M +63,162 +96%
Fidelity International
29
Fidelity International
Bermuda
$3.31M -$2.85M -90,674 -46%
Lord, Abbett & Co
30
Lord, Abbett & Co
New Jersey
$3.09M -$1.66M -52,807 -35%
Charles Schwab
31
Charles Schwab
California
$3.08M +$2.13M +67,650 +226%
MICM
32
Matthews International Capital Management
California
$2.95M +$2.93M +93,307 New
Bank of New York Mellon
33
Bank of New York Mellon
New York
$1.77M +$531K +16,888 +43%
Norges Bank
34
Norges Bank
Norway
$1.52M -$684K -21,755 -31%
Ameriprise
35
Ameriprise
Minnesota
$1.4M -$600K -19,091 -30%
Wells Fargo
36
Wells Fargo
California
$1.26M +$989K +31,443 +373%
California Public Employees Retirement System
37
California Public Employees Retirement System
California
$1.02M +$1.02M +32,445 New
Morgan Stanley
38
Morgan Stanley
New York
$939K -$558K -17,751 -37%
AC
39
Athanor Capital
New York
$843K +$839K +26,690 New
Swiss National Bank
40
Swiss National Bank
Switzerland
$830K +$827K +26,300 New
State of Wisconsin Investment Board
41
State of Wisconsin Investment Board
Wisconsin
$739K +$50.3K +1,600 +7%
SG Americas Securities
42
SG Americas Securities
New York
$735K +$575K +18,282 +367%
AllianceBernstein
43
AllianceBernstein
Tennessee
$699K +$696K +22,127 New
California State Teachers Retirement System (CalSTRS)
44
California State Teachers Retirement System (CalSTRS)
California
$678K – – –
Victory Capital Management
45
Victory Capital Management
Texas
$612K -$3.39M -107,828 -85%
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$594K +$141K +4,487 +31%
PPA
47
Parametric Portfolio Associates
Washington
$545K +$543K +17,272 New
Invesco
48
Invesco
Georgia
$521K +$518K +16,485 New
New York State Common Retirement Fund
49
New York State Common Retirement Fund
New York
$404K +$402K +12,800 New
LCM
50
Laurion Capital Management
New York
$316K – – –
1
2
3 4

RVMD Hedge Fund Activity: Q2 2020 in Review

77 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Revolution Medicines (RVMD) for Q2 2020, worth a combined $1.49B — up 45% from $1.03B a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new RVMD positions and 17 closed out — a net gain of 4 holders — while 24 added to existing stakes and 16 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $39M. The largest seller was BVF Inc, cutting an estimated $18.9M.

  • 77 institutional investors held Revolution Medicines (RVMD) as of Q2 2020, up from 73 in Q1 2020.
  • Funds reported $1.49B of Revolution Medicines stock for Q2 2020, up 45% quarter-over-quarter.
  • 21 funds opened new Revolution Medicines positions in Q2 2020 and 17 closed out, a net change of +4 holders.
  • The largest Revolution Medicines buyer in Q2 2020 was Fidelity Investments, an estimated $39M added.
  • The largest Revolution Medicines seller in Q2 2020 was BVF Inc, an estimated $18.9M sold.

Based on aggregated 13F filings for Q2 2020.